Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Has anyone complained it is behind a paywall, and conducted via a third party? :)
Stuart has previously mentioned on more than one occasion that he is not allowed by the NOMAD to forecast on future recurring revenue based on expressions of interest. As a minimum two months supply are currently being issued to all customers placing an order, Stuart will not have any idea of how many become repeat orders for some months to come so just accept it jimmy and get realistic. There is one group that have no inside information, Cenkos, who in their infinite wisdom have decided to discount any revenue in 2022 from Croda and set the sales revenue of axisbiotix at just £1.2M which equates to 2000 subscribers in their latest note which may explain in part the recent share price action. So, if you believe the pessimistic Cenkos note sell away even though they still have skin as a buy, otherwise if you believe sales by the end of 2022 will be somewhat higher and have the funds to spare, fill your boots while you still can
No forecast on either commercial venture + no comment on cash burn + unjustifiable market cap during a "risk off" period in the market.
Certainly Tom W seemed happy enough following his chat with Stuart so it's passed the Bear test
"...and then I discuss, at length, Skinbiotherapeutics (SBTX) after a chat with CEO Stuart Ashman today and on the back of that I have bought more shares in the company."
Yes agreed belgrano, we know that the market valued SBTX at above double the current price on the just the prospect of Axisbiotix commercialisation and the consumer study output. My thinking is that once we've settled around this current price, IIs will start loading up with the aim of taking profit next year on the back of commercial progress and new revenue streams opening up. And so the cycle will continue. I read a recent post in another BB that I think is soot on. Look at the company, not the SP, i f you want success as a long term investor, which I think is spot on here too.
By offloading 3m stock to in essence multiple traders when the price was above the 55p buy price put them in competition against each other to offload faster, rather than one or two players who might gently offload to stabilise the stock. This snowballs into market sentiment especially when support points were crashed through with the chunky sells we saw. Then momentum and swing traders take notice and react accordingly with more sells. Before you know it price goes into free fall with many unwilling to risk catching the falling knife. I’d also wager that a lot of money is waiting here for the confirmed btm and will return in the hope of an easy 10-20 percent uplift again.
Don’t think there was anything in the results to spook investors, certainly there wasn’t any hype that the fast buck players crave, but just factual reporting till the end our our accounting period. I’ve been reading back on posts and some investors expected to hear current results that had they actually performed due diligence would have known that Stuart had informed us before launch that no results will be released this year. This information was published on this board but clearly not fully understood. May have seen traders trying to get rid of some old overhang as well when it became apparent that their selling down of the opti enforced sale was causing others to also offload as well. If they had made X pounds profit in selling over the 55p strike price it cares less if they also offset a bit in short selling it down under the price and spooking investors big time. Any stops hit is a big bonus for them. They don’t care a fig about any company, just a way to make profits for themselves.
What was it in the results that spooked investors